ESR1 and breast carcinoma: Recent studies have reported that FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis, and crosstalk between the Foxo3a and ER signaling pathways has been demonstrated by several laboratories [31]–[34].